From circadian rhythms to cancer chronotherapeutics

REFERENCES

• Dunlap J.C. Molecular Bases for Circadian Clocks. Cell 1999; 96(2)271–290
   PubMed Web of Science ®Google Scholar
• Shearman L.P., Sriram S., Weaver D.R., Maywood E.S., Chaves I., Zhang B., Kume K., Lee C.C., van der Horst G.T.J., Hastings M.H., Reppert S.M. Interacting Molecular Loops in the Mammalian Circadian Clock. Science 2000; 288: 1013–1019
   PubMed Web of Science ®Google Scholar
• Cermakian N., Sassone-Corsi P. Multilevel Regulation of the Circadian Clock. Nat. Rev. Mol. Cell Biol. 2000; 1: 59–67
   PubMed Web of Science ®Google Scholar
• Lowrey P.L., Takahashi J.S. Genetics of the Mammalian Circadian System: Photic Entrainment, Circadian Pacemaker Mechanisms and Posttranslational Regulation. Annu. Rev. Genet. 2000; 34: 533–562
   PubMed Web of Science ®Google Scholar
• Klein D.C., Moore R.Y., Reppert S.M. Suprachiasmatic Nucleus, the Mind's Clock. Oxford University Press, Oxford 1991
   Google Scholar
• Moore R.Y. Entrainment Pathways and the Functional Organization of the Circadian System. Prog. Brain Res. 1996; 111: 103–119
   PubMed Web of Science ®Google Scholar
• Cassone V.M. Melatonin's Role in Vertebrate Circadian Rhythms. Chronobiol. Int. 1998; 15: 457–473
   PubMed Web of Science ®Google Scholar
• Hrushesky W.J.M., Bjarnason G.A. Circadian Cancer Therapy. J. Clin. Oncol. 1993; 11: 1403–1417
   PubMed Web of Science ®Google Scholar
• Focan C. Circadian Rhythms and Cancer Chemotherapy. Pharmacol. Ther. 1995; 67: 1–52
   PubMed Web of Science ®Google Scholar
• Lévi F. Chronopharmacology of Anticancer Agents. Handbook of Experimental Pharmacology, P.H. Redfern, B. Lemmer. Springer-Verlag, Berlin 1997; 299–331
   Google Scholar
• Lévi F. Cancer Chronotherapy. Lancet Oncol. 2001; 2: 307–315
   PubMed Web of Science ®Google Scholar
• Haus E., Halberg F., Pauly J.E., Cardoso S., Kuhl J.F., Sothern R.B., Shiotsuka R.N., Hwang D.S. Increased Tolerance of Leukemic Mice to Arabinosylcytosine with Schedule-Adjusted to Circadian System. Science 1972; 177: 80–82
   PubMed Web of Science ®Google Scholar
• Halberg F., Haus E., Cardoso S.S., Scheving L.E., Kühl J.F.W., Shiotsuka R., Rosene G., Pauly J.E., Runge W., Spalding J.F., Lee J.K., Good R.A. Toward a Chronotherapy of Neoplasia: Tolerance of Treatment Depends upon Host Rhythms. Experientia 1973; 29: 909–934
   PubMedGoogle Scholar
• Boughattas N., Lévi F., Fournier C., Lemaigre G., Roulon A., Hecquet B., Mathé G., Reinberg A. Circadian Rhythm in Toxicities and Tissue Uptake of 1,2-Diamminocyclohexane(trans-1)oxalatoplatinum (II) in Mice. Cancer Res. 1989; 49: 3362–3368
   PubMed Web of Science ®Google Scholar
• Ohdo S., Makinosumi T., Ishizaki T., Yukawa E., Higuchi S., Nakano S., Ogawa N. Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice. J. Pharmacol. Exp. Ther. 1997; 283: 1383–1388
   PubMed Web of Science ®Google Scholar
• Zhang R., Lu Z., Liu T., Soong S.J., Diasio R.B. Relationship Between Circadian-Dependent Toxicity of 5-Fluorodeoxyuridine and Circadian Rhythms of Pyrimidine Enzymes: Possible Relevance to Fluoropyrimidine Chemotherapy. Cancer Res. 1993; 53: 2816–2822
   PubMed Web of Science ®Google Scholar
• Li X.M., Metzger G., Filipski E., Boughattas N., Lemaigre G., Hecquet B., Filipski J., Lévi F. Pharmacologic Modulation of Reduced Glutathione (GSH) Circadian Rhythms by Buthionine Sulfoximine (BSO): Relationship with Cisplatin (CDDP) Toxicity in Mice. Toxicol. Appl. Pharmacol. 1997; 143: 281–290
   PubMed Web of Science ®Google Scholar
• Tampellini M., Filipski E., Liu X.-H., Li X.-M., François E., Lévi F. Circadian Rhythm in Docetaxel Tolerability and Efficacy in Mice. Cancer Res. 1998; 58: 3896–3904
   PubMed Web of Science ®Google Scholar
• Granda T.G., Lévi F. Tumor-Based Rhythms of Anticancer Efficacy in Experimental Models. Chronobiol. Int. 2002; 19(1)21–41
   PubMed Web of Science ®Google Scholar
• Li X.M., Vincenti M., Lévi F. Pharmacological Effects of Vinorelbine on Body Temperature and Locomotor Activity Circadian Rhythms in B6D2F1 Mice. Chronobiol. Int. 2002; 19(1)43–55
   PubMed Web of Science ®Google Scholar
• Ohdo S., Koyanagi S., Suyama H., Higuchi S., Aramaki H. Changing the Dosing Schedule Minimizes the Disruptive Effects of Interferon on Clock Function. Nat. Med. 2001; 7(3)356–360
   PubMedGoogle Scholar
• Bourin P., Ledain A., Beau J., Mille D., Lévi F. In-Vitro Circadian Rhythm of Murine Bone Marrow Progenitors Production. Chronobiol. Int. 2002; 19(1)57–67
   PubMed Web of Science ®Google Scholar
• Balsalobre A., Damiola F., Schibler U. A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells. Cell 1998; 3: 929–937
   Google Scholar
• Wolfrom C., Chau N.P., Maigne J., Lambert J.C., Ducot B., Guerroui S., Deschatrette J. Evidence for Deterministic Chaos in Aperiodic Oscillations of Proliferative Activity in Long-Term Cultured Fao Hepatoma Cells. J. Cell Sci. 2000; 113(Pt 6)1069–1074
   PubMedGoogle Scholar
• Petrovic A., Oudet C., Stutzmann J. Ultradian Mitotic Rhythms in Cultures of Human Sarcomatous Bone Cells Originating from the Patient Before and After Chemotherapy. Chronobiol Int. 1989; 6: 173–183
   PubMed Web of Science ®Google Scholar
• Xian L.J., Sun J., Cao Q.Y., Ye Y.L., Liu X.H., Li X.M., Lévi F. Circadian Rhythms of DNA Synthesis in Nasopharyngeal Carcinoma Cells. Chronobiol. Int. 2002; 19(1)69–76
   PubMed Web of Science ®Google Scholar
• Haus E. The Chronobiology of Radiation Therapy in Cancer: Animal Models and Human Trials. Chronobiol. Int. 2002; 19(1)77–100
   PubMed Web of Science ®Google Scholar
• Smaaland R., Sothern R.B., Laerum O.D., Abrahamsen J.F. Rhythms in Human Bone Marrow and Blood Cells. Chronobiol. Int. 2002; 19(1)101–127
   PubMed Web of Science ®Google Scholar
• Bjarnason G.A., Jordan R. Rhythms in Human Gastrointestinal Mucosa and Skin. Chronobiol. Int. 2002; 19(1)129–140
   PubMed Web of Science ®Google Scholar
• Bjarnason G.A., Jordan R.C.K., Sothern R.B. Circadian Variation in the Expression of Cell-Cycle Proteins in Human Oral Epithelium. Am. J. Pathol. 1999; 154: 613–622
   PubMed Web of Science ®Google Scholar
• Bjarnason G.A., Jordan R.C., Wood P.A., Li Q., Lincoln D.W., Sothern R.B., Hrushesky W.J., Ben-David Y. Circadian Expression of clock Genes in Human Oral Mucosa and Skin: Association with Specific Cell-Cycle Phases. Am. J. Pathol. 2001; 158(5)1793–1801
   PubMed Web of Science ®Google Scholar
• Practice Parameters for the Use of Actigraphy in the Clinical Assessment of Sleep Disorders. Sleep 1995; 18: 285–287
   PubMed Web of Science ®Google Scholar
• Minors D.S., Akerstedt T., Atkinson G., Dahlitz M., Folkand S., Lévi F., Mormont C., Parkes D., Waterhouse J. The Difference Between Activity when in Bed and out of Bed. I. Healthy Subjects and Selected Patients. Chronobiol. Int. 1996; 13: 27–34
   PubMed Web of Science ®Google Scholar
• Touitou Y., Bogdan A., Lévi F., Benavides M., Auzéby A. Disruption of the Circadian Patterns of Serum Cortisol in Breast and Ovarian Cancer Patients. Relationships with Tumor Marker Antigens. Br. J. Cancer 1996; 74: 1248–1252
   PubMed Web of Science ®Google Scholar
• Mormont M.C., Lévi F. Circadian System Alterations During Cancer Processes: A Review. Int. J. Cancer 1997; 70: 241–247
   PubMed Web of Science ®Google Scholar
• Mormont M.C., Langouët A.M., Claustrat B., Bogdan A., Marion S., Waterhouse J., Touitou Y., Lévi F. Marker Rhythms of Circadian System Function: A Study in Patients with Metastatic Colorectal Cancer and Good Performance Status. Chronobiol. Int. 2002; 19(1)141–155
   PubMed Web of Science ®Google Scholar
• Hryniuk W., Bush H. The Importance of Dose Intensity in Chemotherapy of Metastatic Breast Cancer. J. Clin. Oncol. 1984; 2: 1281–1288
   PubMed Web of Science ®Google Scholar
• Hryniuk W.M., Figueredo A., Goodyear M. Applications of Dose-Intensity to Problems in Chemotherapy of Breast and Colorectal Cancer. Semin. Oncol. 1987; 14: 3–11
   PubMed Web of Science ®Google Scholar
• Hryniuk W.M. The Importance of Dose Intensity in the Outcome of Chemotherapy. Important Advances in Oncology, V.T. De Vita, S. Holman, S.A. Rosenberg. J. B. Lippincott, Philadelphia 1988; 121–142
   Google Scholar
• Granda T.G., Filipski E., D'Attino R.M., Vrignaud P., Anjo A., Bissery M.C., Lévi F. Experimental Chronotherapy of Mouse Mammary Adenocarcinoma MA13/C with Docetaxel and Doxorubicin as Single Agents and in Combination. Cancer Res. 2001; 61: 1996–2001
   PubMed Web of Science ®Google Scholar
• Goldbeter A. Biochemical Oscillations and Cellular Rhythms. The Molecular Basis of Periodic and Chaotic Behaviour. Cambridge University Press, Cambridge 1996
   Google Scholar
• Claude D., Clairambault J. Period Shift Induction by Intermittent Stimulation in a Drosophila Model of PER Protein Oscillations. Chronobiol. Int. 2000; 17: 1–14
   PubMed Web of Science ®Google Scholar
• Goldbeter A., Claude D. Time-Patterned Drug Administration: Insights from a Modelling Approach. Chronobiol. Int. 2002; 19(1)157–175
   PubMed Web of Science ®Google Scholar
• Bruguerolle B. Chronopharmacokinetics. Current Status. Clin. Pharmacokinet. 1998; 35: 83–94
   PubMed Web of Science ®Google Scholar
• Boughattas N., Lévi F., Fournier C., Hecquet B., Lemaigre G., Roulon A., Mathé G., Reinberg A. Stable Circadian Mechanisms of Toxicity of Two Platinum Analogs (Cisplatin and Carboplatin) Despite Repeated Dosages in Mice. J. Pharmacol. Exp. Ther. 1990; 255(2)672–679
   PubMedGoogle Scholar
• Hecquet B., Meynadier J., Bonneterre J., Adenis L., Demaille A. Time Dependency in Plasmatic Protein Binding of Cisplatin. Cancer Treat. Rep. 1985; 69: 79–83
   PubMedGoogle Scholar
• Hrushesky W.J.M., Borch R., Lévi F. Circadian Time Dependence of Cisplatin Urinary Kinetics. Clin. Pharmacol. Ther. 1982; 32: 330–339
   PubMed Web of Science ®Google Scholar
• Lévi F., Metzger G., Massari C., Milano G. Oxaliplatin. Pharmacokinetics and Chronopharmacological Aspects. Clin. Pharmacokinet. 2000; 36(1)1–21
   Google Scholar
• Giacchetti S., Curé H., Adenis A., Tubiana N., Vernillet L., Chedouba-Messali L., Chevalier V., Germa C., Chollet P., Lévi F. Chronomodulated Irinotecan (CPT) Versus Standard Infusion in Patients with Metastatic Colorectal Cancer, a Randomized Multicenter Trial. Proc. ECCO 11, October 21–25, 2001, Lisbon (Portugal). Eur. J. Cancer 2001; 37(Suppl. 6)S309, (abstr. # 1144)
   Google Scholar
• Petit E., Milano G., Lévi F., Thyss A., Bailleul F., Schneider M. Circadian Varying Plasma Concentration of 5-Fluorouracil During 5-Day Continuous Venous Infusion at Constant Rate in Cancer Patients. Cancer Res. 1988; 48: 1676–1679
   PubMed Web of Science ®Google Scholar
• Milano G. Clinical Pharmacokinetics of 5 Fluorouracil with Considerations on Chronopharmacokinetics. Chronobiol. Int. 2002; 19(1)177–189
   PubMed Web of Science ®Google Scholar
• Efficacy of Intravenous Continuous Infusion of Fluorouracil Compared with Bolus Administration in Advanced Colorectal Cancer. J. Clin. Oncol. 1998; 16: 301–308
   PubMed Web of Science ®Google Scholar
• Adler S., Lang S., Langenmayer I., Eibl-Eisbesfeldt B., Rump W., Emmerich B., Hallek M. Chronotherapy with 5-Fluorouracil and Folinic Acid in Advanced Colorectal Carcinoma. Results of a Chronopharmacologic Phase I Trial. Cancer 1994; 73: 2905–2912
   PubMedGoogle Scholar
• Falcone A., Allegrini G., Antonuzzo A., Brunetti I., Pfanner E., Lencioni M., Masi G., Danesi R., Del Tacca M., Conte P. Infusions of Fluorouracil and Leucovorin: Effects of the Timing and Semi-intermittency of Drug Delivery. Oncology 1999; 57: 195–201
   PubMed Web of Science ®Google Scholar
• Langouet A.M., Metzger G., Comisso M., Renée N., Milano G., Mormont M.C., Gruia G., Giacchetti S., Lévi F. Plasma Concentration of 5-Fluorouracil and Mononuclear Cell Dihydropyrimidine Dehydrogenase Activity in Patients Treated with Different Chronomodulated Schedules. Proceedings of the World Conference on Chronobiology and Chronotherapeutics, Ferrara, Italy, September 6–10. Biol. Rhythm Res. 1995; 26(4)409, (abstr. 135)
   Google Scholar
• Sargent D.J., Niedzwiecki D., O'Connel M.J., Schilsky R.L. Recommendation for Caution with Irinotecan, Fluorouracil and Leucovorin for Colorectal Cancer. N. Engl. J. Med. 2001; 345(2)144–145
   PubMedGoogle Scholar
• Rich T.A., Shelton C.H., Kirichenko A., Straume M. Chronomodulated Chemotherapy and Irradiation: An Idea Whose Time Has Come?. Chronobiol. Int. 2002; 19(1)191–205
   PubMed Web of Science ®Google Scholar
• Lévi F., Zidani R., Misset J.L. Randomized Multicentre Trial of Chronotherapy with Oxaliplatin, Fluorouracil, and Folinic Acid in Metastatic Colorectal Cancer. Lancet 1997; 350: 681–686
   PubMed Web of Science ®Google Scholar
• Giacchetti S., Perpoint B., Zidani R., Le Bail N., Faggiuolo R., Focan C., Chollet P., Llory J.F., Letourneau Y., Coudert B., Bertheault-Cvitkovic F., Larregain-Fournier D., Le Rol A., Walter S., Adam R., Misset J.L., Lévi F. Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First Line Treatment of Metastatic Colorectal Cancer. J. Clin. Oncol. 2000; 18(1)136–147
   PubMed Web of Science ®Google Scholar
• Giacchetti S. Chronotherapy of Colorectal Cancer. Chronobiol. Int. 2002; 19(1)207–219
   PubMed Web of Science ®Google Scholar
• Coudert B. Circadian Concepts in Normal and Neoplastic Breast. Chronobiol. Int. 2002; 19(1)221–235
   PubMed Web of Science ®Google Scholar
• Hrushesky W. Circadian Timing of Cancer Chemotherapy. Science 1985; 228: 73–75
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Wood P.A., Hrushesky W.J.M. Circadian Chemotherapy for Gynecological and Genitourinary Cancers. Chronobiol. Int. 2002; 19(1)237–251
   PubMed Web of Science ®Google Scholar
• Focan C. Sequential Chemotherapy and Circadian Rhythm in Human Solid Tumors. Cancer Chemother. Pharmacol. 1979; 3: 197–202
   PubMed Web of Science ®Google Scholar
• Focan C. Chronobiological Concepts for the Treatment of Human Lung Cancer. Chronobiol. Int. 2002; 19(1)253–273
   PubMed Web of Science ®Google Scholar
• Block K.I. Chronomodulated Chemotherapy: Clinical Value and Possibilities for Dissemination in the United States. An Examination of Chronobiologic Chemotherapy Coverage in the U.S. Chronobiol. Int. 2002; 19(1)275–287
   PubMed Web of Science ®Google Scholar
• Focan C. Pharmaco-economic Comparative Evaluation Between Combination Chronotherapy or Standard Chemotherapy for Colorectal Cancer. Chronobiol. Int. 2002; 19(1)289–297
   PubMed Web of Science ®Google Scholar
• Pugliese P., Garufi C., Perrone M., Aschelter A.M., Zappalà A., Terzoli E. Quality of Life and Chronotherapy. Chronobiol. Int. 2002; 19(1)299–312
   PubMed Web of Science ®Google Scholar
• Mormont M.C., Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset J.L., Touitou Y., Lévi F. Marked 24-h Rest–Activity Rhythms Are Associated with Better Quality of Life, Better Response and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status. Clin. Cancer Res. 2000; 6: 3038–3045
   PubMed Web of Science ®Google Scholar
• Mormont M.C., Waterhouse J. Contribution of the Rest–Activity Circadian Rhythm to Quality of Life in Cancer Patients. Chronobiol. Int. 2002; 19(1)313–323
   PubMed Web of Science ®Google Scholar
• Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival. J. Natl Cancer Inst. 2000; 92: 994–1000
   PubMed Web of Science ®Google Scholar
• Halberg F., Cornelissen G., Sothern R.B., Wallach L.A., Halberg E., Ahlgren A., Kuzel M., Radke A., Barbosa J., Goetz F., Buckley J., Mandel J., Shuman L., Haus E., Lakatua D., Sackett L., Berg H., Kawasski T., Ueno M., Uezono K., Matsuoka M., Omae T., Tarquini B., Cagnoni M., Garcia Sainz M., Perez Vega E., Griffiths K., Wilson D., Donati L., Tatti P., Vasta M., Locatelli I., Camagna A., Lauro R., Tritsch G., Wetterberg L., Wendt H.W. International Geographic Studies of Oncological Interest on Chronobiological Variables. Neoplasms—Comparative Pathology of Growth in Animals, Plants and Man, H.E. Kaiser. Williams and Wilkins, Baltimore 1981; 553–596
   Google Scholar
• Rafnsson V., Hrafnkelsson J., Tulinius H. Incidence of Cancer Among Commercial Airline Pilots. Occup. Environ. Med. 2000; 57: 175–179
   PubMed Web of Science ®Google Scholar
• Ballard T., Lagorio S., De Angelis G., Verdecchia A. Cancer Incidence and Mortality Among Flight Personnel: A Meta-analysis. Aviat. Space Environ. Med. 2000; 71: 216–224
   PubMed Web of Science ®Google Scholar
• Stevens R.G., Rea M.S. Light in the Built Environment: Potential Role of Circadian Disruption in Endocrine Disruption and Breast Cancer. Cancer Causes Control 2001; 12: 279–287
   PubMed Web of Science ®Google Scholar
• Davis S., Mirick D.K., Stevens R.G. Night Shift Work, Light at Night and Risk of Breast Cancer. J. Natl Cancer Inst. 2001; 93(20)1557–1562
   PubMedGoogle Scholar
• Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., Colditz G.A. Rotating Night Shifts and Risk of Breast Cancer in Women Participating in the Nurses' Health Study. J. Natl Cancer Inst. 2001; 93(20)1563–1568
   PubMedGoogle Scholar
• Van den Heiligenberg S., Deprés-Brummer P., Barbason H., Claustrat B., Reynes M., Lévi F. Promoting Effect of Constant Light Exposure on Diethylnitrosamine-Induced Hepatocarcinogenesis in Rats. Life Sci. 1999; 64(26)2523–2534
   PubMedGoogle Scholar
• Filipski, E.; King, V. M.; Li, X. M.; Granda, T. G.; Mormont, M. C.; Liu, X. H.; Claustrat, B.; Hastings, M. H.; Lévi, F. Submitted for publication, 2002.
   Google Scholar
• Rivard G., Infante-Rivard C., Hoyeux C., Champagne J. Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Better in the Evening. Lancet 1985; i.i.: 1264–1266
   Google Scholar
• Schmiegelow K., Glomstein A., Kristinsson J., Salmi T., Schroder H., Bjork O. Impact of Morning Versus Evening Schedule for Oral Methotrexate and 6-Mercaptopurine on Relapse Risk for Children with Acute Lymphoblastic Leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J. Pediatr. Hematol. Oncol. 1997; 19: 102–109
   PubMed Web of Science ®Google Scholar
• Blumenthal R.D., Waskewich C., Goldenberg D.M., Lew W., Flefleh C., Burton J. Chronotherapy and Chronotoxicity of the Cyclooxygenase-2 Inhibitor, Celecoxib, in Athymic Mice Bearing Human Breast Cancer Xenografts. Clin. Cancer Res. 2001; 7(10)3178–3185
   PubMedGoogle Scholar
• Harris B., Song R., Soong S., Diasio R.B. Relationship Between Dihydropyrimidine Dehydrogenase Activity and Plasma 5-Fluorouracil Levels: Evidence for Circadian Variation of Plasma Drug Levels in Cancer Patients Receiving 5-Fluorouracil by Protracted Continuous Infusion. Cancer Res. 1990; 50: 197–201
   PubMed Web of Science ®Google Scholar
• El Kouni M.H., Naguib F.N.M., Park K.S., Cha S., Darnowski J.W., Soong S.J. Circadian Rhythm of Hepatic Uridine Phosphorylase Activity and Plasma Concentration of Uridine in Mice. Biochem. Pharmacol 1990; 40: 2479–2485
   PubMed Web of Science ®Google Scholar
• Naguib F.N.M., Soong S.J., El Kouni M.H. Circadian Rhythm of Orotate Phosphoribosyltransferase, Pyrimidine Nucleoside Phosphorylases and Dihydrouracil Dehydrogenase in Mouse Liver. Biochem. Pharmacol. 1993; 45: 667–673
   PubMed Web of Science ®Google Scholar
• Malmary-Nebot M., Labat C., Casanovas A.M., Oustrin J. Aspect Chronobiologique de l'Action du Methotréxate sur la Dihydrofolate Réductase. Ann. Pharm. Fr. 1985; 43: 337–343
   PubMedGoogle Scholar
• Labrecque G., Bélanger P.M., Doré F., Lalande M. 24-Hour Variations in the Distribution of Labeled Microspheres to the Intestine, Liver and Kidneys. Ann. Rev. Chronopharmacol. 1989; 5: 445–448
   Google Scholar
• Scheving L.E., Burns E.R., Pauly J.E., Tsai T.H. Circadian Variation in Cell Division of the Mouse Alimentary Tract, Bone Marrow and Corneal Epithelium. Anat. Rec. 1978; 191: 479–486
   PubMedGoogle Scholar
• Haus E., Lakatua D., Sackett-Lundeen L., White M. Circannual Variation of Intestinal Cell Proliferation in BDF1 Male Mice on Three Lighting Regimens. Chronobiol. Intern. 1984; 1: 185–194
   PubMedGoogle Scholar
• Waldrop R., Saydjari R., Rubin N., Rayford P., Townsend C., Jr, Thompson J. DNA Synthetic Activity in Tumor Bearing Mice. Chronobiol. Intern. 1989; 6: 237–243
   PubMed Web of Science ®Google Scholar